IBM Micromedex Drug Int. APK

IBM Micromedex Drug Int.  Icon
  
3.3/5
155 Ratings
Developer
Mobile Micromedex
Current Version
4.1
Date Published
File Size
13M
Package ID
com.thomson.druginteractions
Price
$ 0.00
Downloads
50000+
Category
Android Apps
Genre
Medical

APK Version History

Version
4.1 (*)
Architecture
all
Release Date
October 25, 2021
Requirement
Android 4.4 and up
  • IBM Micromedex Drug Int. Screenshot
  • IBM Micromedex Drug Int. Screenshot
  • IBM Micromedex Drug Int. Screenshot
  • IBM Micromedex Drug Int. Screenshot
  • IBM Micromedex Drug Int. Screenshot

About Radio FM 90s

With IBM Micromedex Drug Int., clinicians can check a patient’s entire medication list simultaneously for potentially harmful interactions and view severity ratings that range from contraindicated to minor. This app provides insight into:
• Why the drugs in question interact.
• How the results of those interactions will present in the patient.
• Recommendations for monitoring patient outcomes.

IBM Micromedex Drug Int. is a reliable resource for on-the-go access to the industry’s most trusted clinical reference information, providing users with more informed treatment decisions at the point of care. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.

Not sure if your institution subscribes to IBM Micromedex via the internet? Check with your Chief Medical Officer, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.

If the facility you work at subscribes to IBM Micromedex via the internet, follow these instructions to obtain a password:

1.Login to IBM Micromedex through your subscribing facility
2.Click on the “Download Center” link near the top of the application
3.Refer to the detailed downloading instructions, which include your password for activating the application at no charge.

If you cannot locate the “Download Center” link please contact support at https://www.ibm.com/support/home/pages/support-guide/?product=4592217

Existing paid customers will continue to have access to the content going forward.

What's New in this version